• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫检查点抑制剂诱导的皮肤免疫相关不良事件的组织学和免疫特征

Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitors.

作者信息

Pacha Omar, Patel Anisha B, Curry Jonathan L, Haymaker Cara L, Ozirmak Lermi Nejla, Duose Dzifa Yawa, Chen Ken, Hajjar Joud, Naing Aung

机构信息

Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

出版信息

J Immunother Cancer. 2025 Aug 7;13(8):e011401. doi: 10.1136/jitc-2024-011401.

DOI:10.1136/jitc-2024-011401
PMID:40780859
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12336593/
Abstract

BACKGROUND

Although immune checkpoint inhibitors (ICIs) are efficacious, they often cause immune-related adverse events (irAEs), most commonly cutaneous irAEs (CirAEs). The mechanisms underlying CirAEs remain unclear.

METHODS

Attempting to better understand their mechanisms and histology we conducted a prospective study of 15 patients with advanced cancers treated with ICIs who developed grade 2 or higher CirAEs. Clinical and histologic characterization of biopsy specimens of CirAEs was performed. Histologic analysis of patient biopsy specimens were subdivided by epidermal reaction patterns that included spongiotic, lichenoid, and interface dermatitis patterns. A targeted RNA expression assay was used to identify immune markers in CirAE lesions and adjacent unaffected skin samples.

CONCLUSIONS

Compared with adjacent unaffected skin, CirAE lesions had significantly upregulated () and increased M2 macrophages (adjusted p<0.05). Our findings suggest that CirAEs exhibit diverse histologic patterns that may mimic autoimmune skin diseases. The lack of distinct biomarker signatures may indicate complex and heterogeneous mechanisms underlying CirAEs; however, the upregulation of and elevated numbers of M2 macrophages in CirAE lesions suggest and M2 macrophages may be involved in the pathogenesis of these toxic effects. Further investigation to elucidate the molecular determinants of CirAEs and develop targeted therapeutic strategies is warranted.

摘要

背景

尽管免疫检查点抑制剂(ICIs)有效,但它们常引发免疫相关不良事件(irAEs),最常见的是皮肤irAEs(CirAEs)。CirAEs的潜在机制仍不清楚。

方法

为了更好地了解其机制和组织学,我们对15例接受ICIs治疗且发生2级或更高级别CirAEs的晚期癌症患者进行了一项前瞻性研究。对CirAEs活检标本进行了临床和组织学特征分析。患者活检标本的组织学分析根据表皮反应模式进行细分,包括海绵状、苔藓样和界面性皮炎模式。使用靶向RNA表达测定法来鉴定CirAE病变和相邻未受影响皮肤样本中的免疫标志物。

结论

与相邻未受影响的皮肤相比,CirAE病变中 显著上调()且M2巨噬细胞增加(校正p<0.05)。我们的研究结果表明,CirAEs表现出多种组织学模式,可能类似于自身免疫性皮肤病。缺乏独特的生物标志物特征可能表明CirAEs背后存在复杂和异质性的机制;然而,CirAE病变中 的上调和M2巨噬细胞数量的增加表明 和M2巨噬细胞可能参与了这些毒性作用的发病机制。有必要进一步研究以阐明CirAEs的分子决定因素并制定靶向治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e11/12336593/cd73eb36c5e1/jitc-13-8-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e11/12336593/cd73eb36c5e1/jitc-13-8-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e11/12336593/cd73eb36c5e1/jitc-13-8-g001.jpg

相似文献

1
Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitors.免疫检查点抑制剂诱导的皮肤免疫相关不良事件的组织学和免疫特征
J Immunother Cancer. 2025 Aug 7;13(8):e011401. doi: 10.1136/jitc-2024-011401.
2
Cancer type and histology influence cutaneous immunotherapy toxicities: a multi-institutional cohort study.癌症类型和组织学影响皮肤免疫治疗的毒性:一项多机构队列研究。
Br J Dermatol. 2024 Jun 20;191(1):117-124. doi: 10.1093/bjd/ljae053.
3
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
4
Incidence Rates of Cutaneous Immune-Related Adverse Events in Patients with Lung Cancer: A Systematic Review and Meta-Analysis.肺癌患者皮肤免疫相关不良事件的发生率:一项系统评价和荟萃分析
Curr Oncol. 2025 Mar 27;32(4):195. doi: 10.3390/curroncol32040195.
5
Cutaneous Adverse Events and Cancer Survival Prognosis With Immune Checkpoint Inhibitor Treatment: A Systematic Review and Meta-Analysis.免疫检查点抑制剂治疗的皮肤不良反应与癌症生存预后:系统评价和荟萃分析。
JAMA Dermatol. 2023 Oct 1;159(10):1093-1101. doi: 10.1001/jamadermatol.2023.3003.
6
Type 2 immunity links eczematous and lichenoid eruptions caused by immune checkpoint inhibitors.2型免疫将免疫检查点抑制剂引起的湿疹样和苔藓样皮疹联系起来。
J Am Acad Dermatol. 2025 Aug 8. doi: 10.1016/j.jaad.2025.08.008.
7
Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Therapy.抗程序性细胞死亡蛋白 1 和抗程序性细胞死亡配体 1 治疗的患者中皮肤免疫相关不良事件与生存改善相关。
JAMA Dermatol. 2022 Feb 1;158(2):189-193. doi: 10.1001/jamadermatol.2021.5476.
8
Immune checkpoint inhibitors plus platinum-based chemotherapy compared to platinum-based chemotherapy with or without bevacizumab for first-line treatment of older people with advanced non-small cell lung cancer.免疫检查点抑制剂联合铂类化疗对比铂类化疗联合或不联合贝伐珠单抗用于治疗老年人晚期非小细胞肺癌的一线治疗。
Cochrane Database Syst Rev. 2024 Aug 13;8(8):CD015495. doi: 10.1002/14651858.CD015495.
9
Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study.免疫检查点抑制剂引起的多器官免疫相关不良事件及其下游影响:一项回顾性多队列研究。
Lancet Oncol. 2024 Aug;25(8):1053-1069. doi: 10.1016/S1470-2045(24)00278-X. Epub 2024 Jul 15.
10
Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma.肢端雀斑样痣黑色素瘤国际患者队列中程序性细胞死亡蛋白1与细胞毒性T淋巴细胞相关蛋白4联合阻断治疗
Br J Dermatol. 2025 Jan 24;192(2):316-326. doi: 10.1093/bjd/ljae401.

本文引用的文献

1
Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways.免疫检查点抑制剂相关皮肤不良反应的免疫特征分析揭示了两极化的治疗相关通路。
Clin Cancer Res. 2024 Jul 1;30(13):2822-2834. doi: 10.1158/1078-0432.CCR-23-3431.
2
Molecular Mechanisms of Cutaneous Immune-Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitors.免疫检查点抑制剂诱导的皮肤免疫相关不良事件(irAEs)的分子机制。
Curr Oncol. 2023 Jul 18;30(7):6805-6819. doi: 10.3390/curroncol30070498.
3
Thy-1 plays a pathogenic role and is a potential biomarker for skin fibrosis in scleroderma.
Thy-1 在硬皮病的皮肤纤维化中发挥致病作用,并可能成为潜在的生物标志物。
JCI Insight. 2022 Oct 10;7(19):e149426. doi: 10.1172/jci.insight.149426.
4
Diet-induced obesity exacerbates imiquimod-mediated psoriasiform dermatitis in anti-PD-1 antibody-treated mice: Implications for patients being treated with checkpoint inhibitors for cancer.饮食诱导的肥胖会加重抗 PD-1 抗体治疗小鼠的咪喹莫特诱导的银屑病样皮炎:对接受检查点抑制剂治疗癌症的患者的影响。
J Dermatol Sci. 2020 Mar;97(3):194-200. doi: 10.1016/j.jdermsci.2020.01.011. Epub 2020 Jan 24.
5
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.免疫检查点抑制剂治疗患者免疫相关不良反应的管理:美国临床肿瘤学会临床实践指南。
J Clin Oncol. 2018 Jun 10;36(17):1714-1768. doi: 10.1200/JCO.2017.77.6385. Epub 2018 Feb 14.
6
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.与免疫检查点阻断相关的免疫相关不良事件。
N Engl J Med. 2018 Jan 11;378(2):158-168. doi: 10.1056/NEJMra1703481.
7
Diverse types of dermatologic toxicities from immune checkpoint blockade therapy.免疫检查点阻断疗法引发的多种类型皮肤毒性反应。
J Cutan Pathol. 2017 Feb;44(2):158-176. doi: 10.1111/cup.12858. Epub 2016 Dec 21.
8
Immune checkpoint inhibitors in clinical practice: update on management of immune-related toxicities.免疫检查点抑制剂在临床实践中的应用:免疫相关毒性管理的最新进展。
Transl Lung Cancer Res. 2015 Oct;4(5):560-75. doi: 10.3978/j.issn.2218-6751.2015.06.06.
9
Monocyte and macrophage plasticity in tissue repair and regeneration.单核细胞和巨噬细胞在组织修复与再生中的可塑性。
Am J Pathol. 2015 Oct;185(10):2596-606. doi: 10.1016/j.ajpath.2015.06.001. Epub 2015 Jun 26.
10
limma powers differential expression analyses for RNA-sequencing and microarray studies.limma为RNA测序和微阵列研究提供差异表达分析的动力。
Nucleic Acids Res. 2015 Apr 20;43(7):e47. doi: 10.1093/nar/gkv007. Epub 2015 Jan 20.